Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: The REVAMP trial

Archives of General Psychiatry

Volumn 66, Issue 11, 2009, Pages 1178-1188

  Kocsis, James H ^a   Gelenberg, Alan J ^b   Rothbaum, Barbara O ^c   Klein, Daniel N ^g   Trivedi, Madhukar H ^d   Manber, Rachel ^h   Keller, Martin B ⁱ   Leon, Andrew C ^a   Wisniewski, Steven R ^e   Arnow, Bruce A ^h   Markowitz, John C ^a   Thase, Michael E ^f   Friedman, Richard A ^j   Friedman, Edward S ^g   Howland, Robert H ^g   Barkin, Jennifer ^g   Vivian, Dina ^d   Dowling, Frank ^d   D’Zurilla, Thomas ^d   Sunderajan, Prabha ^c   Morris, David ^c   Kleiber, Beverly ^c   Dunlop, Boadie ^k   Ninan, Philip T ^k   Garlow, Steven J ^k   Misiaszek, John ⁱ   Miller, Ivan ^l   Keitner, Gabor ^l   Raffa, Susan ^l   Schatzberg, Alan F ^m   Brent Solvason, H ^m   McCullough, James ⁿ   more..

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g STONY BROOK UNIVERSITY   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k UNIVERSITY OF ARIZONA   (United States)

^l STANFORD UNIVERSITY   (United States)

^m VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁿ Stanford University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; MIRTAZAPINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 70350639046     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2009.144     Document Type: Article

References (55)

1. Harrison WM, Stewart JW. Pharmacotherapy of dysthymic disorder. In: Kocsis JH, Klein DN, eds. Diagnosis and Treatment of Chronic Depression. New York, NY: Guilford Press; 1995:124-145.
2. Keller MB,McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz J, Nemeroff CB, Russell JM, Thase ME, Trivedi M, Zajecka J. A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000; 342(20):1462-1470.
3. Markowitz JC. Psychotherapy of dysthymia. Am J Psychiatry. 1994;151(8):1114-1121.
4. Keller MB, Gelenberg AJ, Hirschfeld RMA, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison W. The treatment of chronic depression, part 2: a doubleblind, randomized trial of sertraline and imipramine. J Clin Psychiatry. 1998; 59(11):598-607.
5. Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J. Imipramine treatment for chronic depression. Arch Gen Psychiatry. 1988;45(3):253-257.
6. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry. 1996; 53(9):777-784.
7. Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry. 1998;59(11):608-619.
8. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord. 1997;45(1-2):5-18.
9. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression Psychol Med. 1995;25(6):1171-1180.
10. Cornwall PL, Scott J. Partial remission in depressive disorders. Acta Psychiatr Scand. 1997;95(4):265-271.
11. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY:Raven Press; 1995:1081-1097.
12. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243-1252.
13. Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry. 2006;163(7):1161-1172.
14. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME,McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ; STAR*D Study Team. A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1519-1530, quiz 1665.
15. Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RMA, LaVange LM, Klein DN, Fawcett J, Harrison W. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry. 2002;59(3):233-239.
16. Manning DW, Markowitz JC, Frances AJ. A review of combined psychotherapy and pharmacotherapy in the treatment of depression. J Psychother Pract Res. 1992;1(2):103-116.
17. Roth A, Fonagy P. What Works for Whom? A Critical Review of Psychotherapy Research. New York, NY: Guilford Press; 1996.
18. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive Disorders. Chichester, England: John Wiley & Sons; 1999:161-206. WPA Series in Evidence and Experience in Psychiatry; vol 1.
19. Blom MB, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, van Dyck R. Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom. 2007;76(5):289-297.
20. Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks MH. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. J Affect Disord. 2005;89(1-3):167-175.
21. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999; 56(9):829-835.
22. Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007;164(5):739-752.
23. Friedman RA. Social and occupational adjustment in chronic depression. In: Kocsis JH, Klein DN, eds. Diagnosis and Treatment of Chronic Depression. New York, NY: Guilford Press; 1995:89-102.
24. Klein DN, Taylor EB, Harding K, Dickstein S. Double depression and episodic major depression: demographic, clinical, familial, personality, and socioenviron- mental characteristics and short-term outcome. Am J Psychiatry. 1988;145(10):1226-1231.
25. McCullough JP. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2000.
26. Schatzberg AF, Rush AJ, Arnow BA, Banks P, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005;62(5):513-520.
27. Crismon ML, Trivedi MH, Pigott TA, Rush AJ, Hirschfeld RMA, Kahn DA, DeBattista C, Nelson CJ, Nierenberg AA, Sackeim HA, Thase ME. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry. 1999;60(3):142-156.
28. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am. 2003;26(2):457-494, x.
29. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-855.
30. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis-I Disorders, Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Dept, New York State Psychiatric Institute; 1995.
31. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
32. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC:Dept of Health, Education, and Welfare; 1976. Publication No. (ADM) 76-338.
33. Thase ME, Rush AJ. When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(suppl 13):23-29.
34. Rush AJ, Thase ME. Strategies and tactics in the treatment of chronic depression. J Clin Psychiatry. 1997;58(suppl 13):14-22.
35. Depression Guideline Panel. Clinical Practice Guideline No. 5: Depression in Primary Care. Vol 2. Rockville, MD: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR Publication No. 93-0551.
36. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(4)(suppl):1-45.
37. Epstein PS, Fawcett J. Addendum to Clinical Management-Imipramine/ Placebo Administration Manual: NIMH Treatment of Depression Collaborative Research Program. Chicago, IL: Rush Presbyterian-St Lukes Medical Center; 1982.
38. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH; NIMH Treatment of Depression Collaborative Research Program. Clinical management-imipramine/ placebo administration manual. Psychopharmacol Bull. 1987;23(2):309-324.
39. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry. 1989;46(11):971-983.
40. McCullough JP. Patient Manual for the Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2002.
41. McCullough JP. Training Manual for Diagnosing and Treating Chronic Depression:Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2001.
42. Rogers CR. Client-Centered Therapy. Boston, MA: Houghton Mifflin; 1951.
43. Frank JD. Eleventh Emil A. Gutheil memorial conference: therapeutic factors in psychotherapy. Am J Psychother. 1971;25(3):350-361.
44. Markowitz JC, Manber R, Rosen P. Therapists’ responses to training in brief supportive psychotherapy. Am J Psychother. 2008;62(1):67-81.
45. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583.
46. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548.
47. Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med. 1999;29(4):869-878.
48. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA; for the STAR*D Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-79.
49. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics. 1994;50(4):933-944.
50. Kocsis JH, Gelenberg AJ, Rothbaum B, Klein DN, Trivedi MH, Manber R, Keller MB, Howland R, Thase ME. Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 759 patients presenting for treatment. J Affect Disord. 2008;110(1-2):55-61.
51. Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, Thase ME. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry. 2009;70(3):354-361.
52. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP Jr, Weiss P, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A. 2003;100(24):14293-14296.
53. Rush AJ. STAR*D: what have we learned?AmJ Psychiatry. 2007;164(2):201-204.
54. Hollon SD. Does cognitive therapy have an enduring effect? Cognit Ther Res. 2003;27(1):71-75.
55. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O’Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R. Prevention of relapse following cognitive therapy versus medication in moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):417-422.